Iris Medicine

Iris Medicine

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://irismedicine.com/

Last Round

Grant

Sep 28, 2025

Total Funding Raised

$3M

Momentum Score

25 /100

Company Overview

Iris Medicine is a biotechnology company pioneering small binding RNA (sbRNA) technology to develop therapies for genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

small binding RNAsbRNA platformRNA therapeuticsRNA therapyrepeat expansion disordersHuntington's disease treatmentALS treatmentallele-selective therapymRNA modulationSpinocerebellar Ataxiasdrug discovery platformneurological disease treatmentgene therapyC9orf72 ALSnon-viral delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Iris Medicine Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Iris Medicine Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantSep 28, 2025
SeedMay 1, 2020

Iris Medicine Investors

Notable investors and investment history

Iris Medicine Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Iris Medicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Iris Medicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range11
Year Founded2019
Last FundingSep 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.